POPULARITY
2 episodes with hepatologist
2 episodes with hepatologist
2 episodes with hepatologist
2 episodes with hepatologist
2 episodes with hepatologist
2 episodes with hepatologist
2 episodes with hepatologist
2 episodes with hepatologist
4 episodes with hepatologist
This week's expert, Hepatologist and Key Opinion Leader Scott Friedman, joins Roger to discuss advances in acceptance of gene therapy and knowledge in other areas of basic liver science. When discussing science, he pays particular attention to findings on the diversity of stellate cells and his interest in CAR-T as a therapy for liver disease.This conversation starts with Scott discussing gene therapy. Specifically, he applauds the idea that gene therapy is becoming accepted in many diseases after a faulty start years ago, due to an unfortunate patient death in a badly controlled trial. He comments that this acceptance has unique benefits in liver disease because the liver can regenerate so much faster and more efficiently than other organs. He mentions some of the rare liver diseases in which patients are benefiting from gene therapy, and notes that we now have gene therapies and early-stage trials to target PNPLA3 and other genes associated with MASH and MASH cirrhosis. Next, Scott discusses stellate cells, which he has discussed in earlier episodes of SurfingMASH. Science is increasingly demonstrating how many different types of heterogeneous stellate cells exist. As Scott puts it, these cells "come in many flavors," each of which plays a different role in cell generation or cell death. In fact, the specific therapeutic challenges that present themselves may vary as a patient moves along the pathway from F1 to F2 to F3 to F4. Further, we are learning that there may be several different forms of MASH to present differently at a cellular level. This makes tremendous sense, given that no one drug has proven successful in even a significant majority of patients yet. As the conversation winds down, Scott shares what he describes as a "sobering note" about the state of research funding in America in 2025. As he notes, there are certain kinds of applied and developmental research that private companies do well, but other kinds of basic research that only occur when funded in public and not-for-profit sectors. As a specific example, he cites CRISPR, initially funded publicly and now in the hands of biotech companies, which is used to treat a variety of diseases more effectively than they could have been treated before, if at all. He also comments that a poor early commercial decision slowed the development of statins.
This week's expert, Hepatologist and Key Opinion Leader Mazen Noureddin, joins Roger to discuss major advances in drug development over the past year. He covers a range of different drug classes, focusing on stages of development and the range of options within each class. First, Mazen discusses a tremendously exciting group of FGF-21 agents, specifically mentioning Akero Therapeutics's efruxifermin, 89bio's pegozafermin, and Boston Pharmaceuticals's efimosfermin. He points to efruxifermin's 96-week results to suggest that FGF-21s might be appropriate for a wide range of patients, the idea that the drug's duration of effect may make the idea of “induction therapy” less appropriate, and the exciting early data on cirrhosis patients. He also mentions pegozafermin's publication of data in the New England Journal of Medicine and efimosfermin's promising data based on monthly dosing. Next, Mazen provides some detail on the various incretin agonist options, why hepatologists are particularly excited about combinations that include a glucagon agent, and what kinds of results we might expect in upcoming trials. Finally, Mazen discusses other promising compounds in later-stage development, including the pan-PPAR lanifibranor and the FASN inhibitor denifenstat. He notes ongoing work on new classes and combination therapies.
Did you know that PPIs are one of the most commonly prescribed medications in Australia according to PBS data? Join Kristin for a deep dive into proton pump inhibitors as she chats with Gastroenterologist, Hepatologist and Gastrointestinal endoscopist, Dr Kostas Brooks. What dose PPIs should patients actually be taking? How do you manage rebound symptoms? Listen in to find out.
In this episode, host Courtney Allison discusses the latest studies on the health risks associated with alcohol use with Dr. Robert Brown, chief of Gastroenterology and Hepatology at NewYork-Presbyterian and Weill Cornell Medicine. They discuss how alcohol affects various organs, including your liver, heart, and brain, as well as its link to several cancers. Dr. Brown discusses the cultural perception of alcohol, the current guidelines around safe drinking limits, and how binge drinking harms the body.
In this episode, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with primary biliary cholangitis (PBC), discuss the burden of pruritus in PBC and the impact it has on quality of life, including both physical and mental health, from a patient's perspective. Presenters:Marlyn J. Mayo, MDProfessor of Internal MedicineDivision of Digestive & Liver DiseasesUT Southwestern Medical CenterDallas, TexasStuart C. Gordon, MDProfessor of MedicineWayne State University School of MedicineDirector, Division of HepatologyHenry Ford HealthDetroit, MichiganPam Rivard, RNPerson living with PBC Link to full program: https://bit.ly/4gDGDaB
Although there is currently no FDA-approved treatment for pruritus in primary biliary cholangitis (PBC), symptoms can be mitigated with nonpharmacologic or pharmacologic agents. In this episode, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss the clinical management of pruritus in PBC, including:Pruritus assessment toolsOptimal use of tools, including frequency of assessmentCurrent management of pruritusNonpharmacologic interventionsPharmacologic agentsStrategies to optimize assessment and management of pruritusCollaborative careDevelopment of a treatment planOngoing assessment and adjustment of therapyResources and support for patientsPresenters:Marlyn J. Mayo, MDProfessor of Internal MedicineDivision of Digestive & Liver DiseasesUT Southwestern Medical CenterDallas, TexasStuart C. Gordon, MDProfessor of MedicineWayne State University School of MedicineDirector, Division of HepatologyHenry Ford HealthDetroit, MichiganPam Rivard, RNPerson living with PBCLink to full program: https://bit.ly/3Dnfb2E
Clinical gaps in the treatment of pruritus in primary biliary cholangitis (PBC) remain. In this episode, taken from a recent symposium, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss emerging therapies currently in clinical trials for the management of this disease that can dramatically affect patients' quality of life.Listen as they discuss:Gaps in current managementPatient perspectives: why we should not dismiss itching as an underlying psychologic problemPPAR agonists and how they affect pruritusBEZURSO and FITCH ELATIVEENHANCE and RESPONSEIBATs (inhibitors of bile acid transport)GLIMMERCommon questionsPresenters:Marlyn J. Mayo, MDProfessor of Internal MedicineDivision of Digestive & Liver DiseasesUT Southwestern Medical CenterDallas, TexasStuart C. Gordon, MDProfessor of MedicineWayne State University School of MedicineDirector, Division of HepatologyHenry Ford HealthDetroit, MichiganPam Rivard, RNPerson living with PBCLink to full program: https://bit.ly/3Dnfb2E
In this episode, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with primary biliary cholangitis (PBC), discuss the burden of pruritus in PBC and the impact it has on quality of life, including both physical and mental health, from a patient's perspective.Presenters:Marlyn J. Mayo, MDProfessor of Internal MedicineDivision of Digestive & Liver DiseasesUT Southwestern Medical CenterDallas, TexasStuart C. Gordon, MDProfessor of MedicineWayne State University School of MedicineDirector, Division of HepatologyHenry Ford HealthDetroit, MichiganPam Rivard, RNPerson living with PBCLink to full program: https://bit.ly/4gDGDaB
Although there is currently no FDA-approved treatment for pruritus in primary biliary cholangitis (PBC), symptoms can be mitigated with nonpharmacologic or pharmacologic agents. In this episode, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss the clinical management of pruritus in PBC, including:Pruritus assessment toolsOptimal use of tools, including frequency of assessmentCurrent management of pruritusNonpharmacologic interventionsPharmacologic agentsStrategies to optimize assessment and management of pruritusCollaborative careDevelopment of a treatment planOngoing assessment and adjustment of therapyResources and support for patientsPresenters:Marlyn J. Mayo, MDProfessor of Internal MedicineDivision of Digestive & Liver DiseasesUT Southwestern Medical CenterDallas, TexasStuart C. Gordon, MDProfessor of MedicineWayne State University School of MedicineDirector, Division of HepatologyHenry Ford HealthDetroit, MichiganPam Rivard, RNPerson living with PBCLink to full program: https://bit.ly/3Dnfb2E
Clinical gaps in the treatment of pruritus in primary biliary cholangitis (PBC) remain. In this episode, taken from a recent symposium, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss emerging therapies currently in clinical trials for the management of this disease that can dramatically affect patients' quality of life.Listen as they discuss:Gaps in current managementPatient perspectives: why we should not dismiss itching as an underlying psychologic problemPPAR agonists and how they affect pruritusBEZURSO and FITCH ELATIVEENHANCE and RESPONSEIBATs (inhibitors of bile acid transport)GLIMMERCommon questionsPresenters:Marlyn J. Mayo, MDProfessor of Internal MedicineDivision of Digestive & Liver DiseasesUT Southwestern Medical CenterDallas, TexasStuart C. Gordon, MDProfessor of MedicineWayne State University School of MedicineDirector, Division of HepatologyHenry Ford HealthDetroit, MichiganPam Rivard, RNPerson living with PBCLink to full program: https://bit.ly/3Dnfb2E
Expand your NAFLD/MASLD knowledge! Expert guest Dr. Elliot Tapper (@ebtapper) shares his framework for approaching NAFLD/MASLD and the treatment tools he recommends including lifestyle modifications and medications. Claim CME for this episode at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments Intro Rapid Fire Segment Case 1 Part 1 NAFLD/MASLD terminology and differential diagnoses PEth testing Diagnostic tools for NAFLD/MASLD: Fib4 Score Imaging When to Refer to a Hepatologist? Treatment options Lifestyle modifications Role of GLP-1 agonists Role of new FDA approved medications Outro Credits Producer: Sai S Achi, MD, MBA, FACP; Matthew Watto MD, FACP Writer, Show Notes, Cover Art, and Infographics: Sai S Achi, MD MBA, FACP Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP Reviewer: Leah Witt MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Dr. Elliot Tapper MD Sponsor: Freed You can try Freed for free right now by going to freed.ai. And listeners of Curbsiders can use code CURB50 for $50 off their first month. Sponsor: The University of Vaginia Visit uvahealth.com website to explore this exceptional opportunity and submit your application today. Sponsor: Beginly Health Ready to take control of your job search? Visit beginlyhealth.com/curbsiders to get started.
A new organ-saving technology is being used by Intermountain Health. They say this is the first program of its kind in Utah. Medical Director of Hepatologist at Intermountain Healthcare Dr. Richard Gilroy joined me on Utah's Noon News to discuss the details of this program.
CME credits: 1.00 Valid until: 13-06-2025 Claim your CME credit at https://reachmd.com/programs/cme/noninvasive-tests-for-clinically-significant-fibrosis-thats-the-hepatologists-job-right/26257/ This series of bite-sized episodes will provide important information on MASLD and MASH in patients with type 2 diabetes. Drs. Naim Alkhouri and Robert Eckel and physician assistant Tessa Janovsky discuss best practices for screening, diagnosis, treatment, and management of MASH/MASLD.
In this episode we speak with Dr. Supriya Joshi about taking care of our liver with diet and lifestyle tools. After completing her Medical degree at the University of Western Ontario, Dr Supriya Joshi completed residency in Internal Medicine, Gastroenterology and a further fellowship in Hepatology at The University of Toronto. After working at Toronto Western Hospital as a clinical Hepatologist for a few years she has been working at The Credit Valley Hospital, Trillium Health Partners in Mississauga, Ontario since 2004 as a Gastroenterologist and Hepatologist. She is a Lecturer at the Tremerty Faculty of Medicine at The University of Toronto. She enjoys speaking and educating others on viral hepatitis and metabolic health related fatty liver disease and its management. She is the Medical Advisor and board member of Fatty Liver Alliance which is a patient advocacy organization. She has been writing and educating the public about the negative impact of poor diet on metabolic health for years and has been a guest on CBC Marketplace to highlight these issues as well as an invited guest on Podcasts and social media platforms. Outside of medicine she is married and is a mom to 3 young kids and enjoys travel, exercise and trying to improve her cooking skills. Learning Points: • Misconceptions about ‘fatty liver' disease • Integrating medical and life style care for ‘fatty liver' disease • Fatty liver disease and insulin resistance connection Social Media: https://www.instagram.com/liverhealthmd/ https://www.linkedin.com/in/supriya-joshi-66598639/?originalSubdomain=ca Clinic Site https://www.liverhealthclinic.com/
Dr. Bilal Hameed, a Gastroenterologist and Hepatologist from the University of California San Francisco joins us for a discussion about alcohol-associated liver disease. A condition that has been on the rise, particularly since the COVID-19 pandemic, alcohol-associated liver disease is not just a physical deterioration of the liver but complicated by the nature of personal lifestyle choices involving alcohol consumption. Dr. Hameed shares his expertise on symptoms to watch out for, treatment options, and offers tips for having candid conversations with your healthcare provider. This episode is brought to you in partnership with the American College of Gastroenterology's Patient Care Committee.
In this episode, Maria Buti, MD, and her patient discuss opportunities to optimize care for people living with hepatitis B virus (HBV), including: Barriers to HBV screening, including patient- and provider-specific barriers (eg, lack of education, failure to disclose or discuss risk factors, perceived low risk, stigma)Applying CDC recommendations for universal HBV screening in adults Strategies to improve HBV transitions of care (eg, improved education, simplify criteria for screening and monitoring, alternative testing sites)Importance of testing close contacts for HBV after initial diagnosis and promoting HBV vaccination Presenter: Maria Buti, MDProfessor of MedicineSenior ConsultantLiver UnitHospital Universitario Valle HebronBarcelona, SpainContent based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.Link to full program:https://bit.ly/49TuZ8UGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.
Dr Ahmed Omar Kaseb from the University of Texas MD Anderson Cancer Center in Houston, Texas, and Prof Arndt Vogel from Schwartz Reisman Liver Research Centre in Toronto, Ontario, discuss the optimal selection and sequencing of checkpoint inhibitor therapy for patients with hepatobiliary cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/ASCOGI24/Hepatobiliary1).
In this episode, Nancy Reau, MD, and her patient discuss opportunities to optimize care for people living with hepatitis B virus and hepatitis delta virus, including:The importance of patient education along the care continuumEnsuring smooth transitions of care and communication between medical teamsScreening hepatitis delta in persons with chronic hepatitis BManaging hepatitis delta, including considerations for clinical trialsPromoting patient advocacyPresenter: Nancy Reau, MDProfessor of Medicine Chief, Section of HepatologyAssociate Director, Solid Organ TransplantationRichard B. Capps Chair of HepatologyRush University Medical CenterChicago, IllinoisContent based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.Link to full program: bit.ly/3SrMuGOGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.
In this episode, we review the epidemiology, diagnostic criteria, investigation and management of hepatitis B. Our medicine minute reviews the current CDC guidelines and recommendations for screening in the general population.Written by: Drs. Amine Zoughlami and Ikram Abow-MohamedReviewed by: Dr. Phillip wong (Hepatologist) and Dr. Sanabelle Zaabat (General Internist)Support the show
Dr Philip Smith, Deputy Editor of Frontline Gastroenterology and Social Media Associate Editor and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK and Dr Mohsan Subhani, Trainee Associate Editor of Frontline Gastroenterology and Gastroenterology Registrar in the East Midland Deanery, Nottingham, UK interview Dr Dina Mansour, Consultant Gastroenterologist and Hepatologist, Gateshead Health NHS Foundation Trust, Newcastle, UK and Dr Coral Hollywood, Consultant Hepatologist at Gloucestershire Hospitals NHS Foundation Trust, UK on the paper 'British Society of Gastroenterology Best practice guidance: Outpatient management of cirrhosis Part 3 - Special circumstances' published online in Frontline Gastroenterology in July 2023: https://fg.bmj.com/content/14/6/474 Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229
Dr Philip Smith, Deputy Editor of Frontline Gastroenterology and Social Media Associate Editor and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK, and Dr Philip Dunne, Trainee Associate Editor of Frontline Gastroenterology and Gastroenterology Registrar in the West of Scotland deanery, Glasgow UK interviews Dr Dina Mansour, Consultant Gastroenterologist and Hepatologist, Gateshead Health NHS Foundation Trust, Newcastle, UK and Dr Lynsey Corless, Consultant Hepatologist, Hull Universities Teaching Hospitals NHS Trust, UK, on the paper 'British Society of Gastroenterology Best practice guidance: outpatient management of cirrhosis, part 2 – decompensated cirrhosis' published online in Frontline Gastroenterology in July 2023: https://fg.bmj.com/content/14/6/462 Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229
Dr. Steven Herrine is the chair of medical education and professor of medicine here at SKMC at Jefferson and a practicing hepatologist and gastroenterologist. He grew up in NYC and studied math and history at Oberlin College, after which he spent a few years as a chef, and then went to Jefferson medical school, Penn, for IM residency and Jefferson for GI/hepatology, where he has stayed since. He has won multiple awards for teaching, including IM residency teacher of the year, which makes sense because he now runs medical education as the chair here at SKMC. This is a scary interview for me because if I say anything bad, Dr. Herrine can of course, kick me right out of medical school with only a couple months left. Sep 25th___0:00 - Intro1:17 - From Being a Chef to Doing Medicine5:39 - What Is Hepatology?6:12 - Why Hepatology?9:50 - What Was Fellowship Like?10:48 - Choosing the Kind of Practice That You Want to Do17:46 - Best Thing About Being a Hepatologist20:29 - Worst Thing About Being a Hepatologist22:07 - How to Get Into Dean/Chair Positions?24:23 - An Average Week/Day Balancing Clinic and Dean Position27:39 - Most Surprising/Unexpected Thing About Being a Dean29:50 - Formalities and Processes for Changing Med School Curriculum32:03 - Main Factors in Change33:00 - LCME Guidelines on Curriculum35:06 - Being the Dean of Medical Education37:21 - Lessons Learned After Being in Medical Education for 20+ Years 39:52 - Social Science & Medicine43:48 - Deciding on Online and On-Site Classes47:28 - Medical Education Changing Over the Years49:57 - Differences Between Successful and Unsuccessful Students53:25 - Medical Education During COVID-1957:56 - Future of Your Career59:32 - If I Give You $100 Million, What Would You Do?1:00:57 - Advice to People Entering Medicine1:02:36 - What Advice Would You Give Your Med Student Self?1:03:30 - Any Mistakes That You Made Throughout Your Career?1:05:14 - Book Recommendations1:08:28 - Closing Message for People Looking Into Hepatology1:08:52 - Closing Message for People Going Into Medicine1:10:03 - Tips for Making Great Graphics for Teaching1:11:05 - Giving a Good Experience for Students at SKMC&Jefferson1:13:55 - Closing Message1:15:13 - Outro__ResourcesBeing There by Jerzy Kosinski: https://a.co/d/3a8BVrZ Undaunted Courage by Stephen E. Ambrose: https://a.co/d/cS4QFdF ___View the Show Notes Page for This Episode for transcript and more information: zhighley.com/podcast___Connect With ZachMain YouTube: @ZachHighley Newsletter: https://zhighley.com/newsletter/Instagram: https://www.instagram.com/zachhighley/?hl=enWebsite: https://zhighley.comTwitter: https://twitter.com/zachhighleyLinkedln: https://www.linkedin.com/in/zach-highley-gergel-44763766/Business Inquiries: zachhighley@nebula.tv___Listen for FreeSpotify: https://open.spotify.com/show/23TvJdEBAJuW5WY1QHEc6A?si=cf65ae0abbaf46a4Apple Podcast: https://podcasts.apple.com/us/podcast/the-zach-highley-show/id1666374777___Welcome to the Zach Highley Show, where we discuss personal growth and medicine to figure out how to improve our lives. My name is Zach a Resident Physician in Boston. Throughout these episodes I'll interview top performers from around the world in business, life, and medicine in hopes of extracting the resources and techniques they use to get to the top.The best way to help the show is share episodes on any platform. If you think a friend or family member will like a certain episode, send it to them!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Dr Philip Smith, Deputy Editor of Frontline Gastroenterology and Social Media Associate Editor and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK and Dr Gio Sheiybani, Frontline Gastroenterology Trainee Editor and Gastroenterology Registrar in the Royal United Hospital, Bath, UK interview Dr Dina Mansour, Consultant Gastroenterologist and Hepatologist, Gateshead Health NHS Foundation Trust, Newcastle, UK and Professor Dhiraj Tripathi, Consultant Hepatologist and Clinical Director of Research at University Hospitals Birmingham NHS Foundation Trust, on the paper 'British Society of Gastroenterology Best Practice guidance: outpatient management of cirrhosis Part 1 – compensated cirrhosis' published online in Frontline Gastroenterology in July 2023 and available online: https://fg.bmj.com/content/14/6/453 Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229
Dr Ghassan Abou-Alfa from Memorial Sloan Kettering Cancer Center in New York and Dr Daneng Li from City of Hope Comprehensive Cancer Center in Duarte, California, discuss the implications of recent data sets for the management of hepatocellular carcinoma moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://researchtopractice.com/PostESMOGI23/HCC)
In this episode you meet John, Paul and Will who are three liver doctors (Hepatologist) and hear about a new podcast - the LiverHealth POD. A Podcast aimed for anyone interested in health or curious about the liver. This is the introductory episode. In this series we'll discuss a range of common liver conditions such as hepatitis, cirrhosis and fatty liver and also practical things you can do to keep your liver healthy and optimise your overall well being.
Did you know people with constipation have a higher all cause mortality than those with normal bowel function? Join Natalie and Kristin as they get bogged down in the details of how to treat and manage constipation with Sydney based Gastroenterologist, Hepatologist and Gastrointestinal endoscopist, Dr Kostas Brooks.
Welcome to episode 31! In this week's coffee with consultants feature, we break new ground by featuring our first interview with a consultant from the Western Cape! Thanks to the nomination of their intern curator by a number of the Groote Schuur interns, I had the immense privilege and honour of interviewing hepatologist Professor Mark Sonderup at the Liver Clinic at Groote Schuur Hospital. Professor Mark Sonderup is an internal medicine physician and specialist Hepatologist at the University of Cape Town (UCT) and Groote Schuur Hospital (GSH). He has research interests in the treatment of chronic and acute liver diseases, including HIV, viral hepatitis and drug-induce liver injuries. We discussed his journey into and through medicine, including his pharmacy degree which he completed prior to entering medicine at UCT, his internship experiences, and what led to him choosing to specialise in internal medicine, with the experience of becoming a registrar at the height of the HIV/AIDS crisis in South Africa, as well as some of the interesting factors around that time such as the HIV-denialism that had wide-reaching implications for patients and the public health system. In the latter half of this episode, we also discussed his role mentoring, monitoring and guiding interns and medical students, and some of the observations he has made from this and what advice he has for junior doctors. If you're someone who has been grappling with indecision, or experienced self-doubt in your journey to becoming and being a doctor, you'll definitely want to stick around for that because it is seriously rich and wise insight and advice to digest and take to heart. I thoroughly enjoyed our conversation and I'm sure you will as well. For more information about anything we discussed in this episode, or to share your thoughts on it, send an email to drcoffeeza@gmail.com.
Rashmee Patil, M.D.Hepatologist, CEO Pinnacle Research Non Alcoholic Fatty Liver Disease is a silent, slowly progressive killer and will soon be a top cause of death in the US. Pinnacle Research has the top researchers and thought leaders in the world in San Antonio and surrounding South Tx back yard. Join Dr Pinkston with Pinnacle's new dazzling CEO to discuss the future of liver treatments and free screening. See omnystudio.com/listener for privacy information.
In this episode of Magic City MedCast, MS4 Vince Bolus sits down with the ever-charismatic Dr. David Fettig to discuss the field of Transplant Hepatology. Tune in for a captivating conversation about the trends in liver disease in the state of Alabama, the process of liver transplantation, patient coaching strategies, and much more! Credits: This[...]
The Plant Free MD with Dr Anthony Chaffee: A Carnivore Podcast
Dr Pran Yoganathan is a Sydney based Consultant Gastroenterologist and Hepatologist who practices and preaches an animal based diet for himself and his patients. During his career he realized that the standard practices alone weren't giving his patients the help that they needed, so he changed the practice to addressing the elephant in the room: nutrition. This has shown huge benefits to both himself, his patients, and his growing family. He was also my teammate in the recent ACNEM Carnivore vs Vegan debate November 2021, link below in Resources if you haven't seen it yet. Join me in this great conversation with a true expert in gut health and nutrition. Dr Pran Yoganathan INSTAGRAM: https://www.instagram.com/dr_pran_yoganathan/ Dr Pran Yoganathan's Practice 76 Showground road castle hill, NSW 1300580239 SPONSORS: X3 bar system with discount code "DRCHAFFEE" https://www.kqzyfj.com/click-100676052-13511487 THE CARNIVORE BAR: Discount Code "Anthony" for 10% off all orders! https://the-carnivore-bar.myshopify.com/?sca_ref=1743809.v3IrTuyDIi CARNIVORE CRISPS: Discount Code "DRCHAFFEEMD" for 10% off all orders! www.carnivorecrisps.com Shop Amazon https://www.amazon.com/shop/anthonychaffeemd?ref=ac_inf_hm_vp FOLLOW AND CONTACT ME: PATREON for early releases, bonus content, and weekly Zoom meetings https://www.patreon.com/AnthonyChaffeeMD Sign up for our 30-day carnivore challenge and group here! https://www.howtocarnivore.com/ INSTAGRAM: @anthonychaffeemd www.instagram.com/anthonychaffeemd/ TWITTER: @Anthony_Chaffee TIKTOK: @AnthonyChaffeeMD Apple Podcast: The Plant Free MD https://podcasts.apple.com/au/podcast/the-plant-free-md-podcast/id1614546790 Spotify: The Plant Free MD https://open.spotify.com/show/0WQtoPLuPMWWm3ZT3DYXzp?si=PPc2rXZzQXuzjIRK__SEZQ For Consults or collaborations, please email me at the below address. Please understand that I can not give advice over email, but only in a consultation setting: AnthonyChaffee@gmail.com For more of my interviews and discussions, as well as other resources, go to my Linktree at: https://linktr.ee/DrChaffeeMD OR my website at: www.TheCarnivoreLife.com And please like and subscribe to my podcast here and Apple/Google podcasts, as well as my YouTube Channel to get updates on all new content! Resources: ACNEM Healthy Debate (Carnivore v Vegan) https://vimeo.com/644611724/b94e6a7cb0 My expanded Carnivore vs Vegan arguments https://youtu.be/a_zSIpUjfS4 Elemental diet found to be as or more effective as prednisone for acute crohns exacerbations in clinical trial https://www.bmj.com/content/288/6434/1859.abstract Elemental diet better than steroids in children; clinical trial https://adc.bmj.com/content/62/2/123.short Elemental diet better than polymeric diet in treating Crohn's and keeping in remission. Quick absorption, less stress on cut, EG fiber opposite of this. https://www.sciencedirect.com/science/article/pii/014067369090936Y Exclusion diet keeps Crohn's patients in remission for up to 51 months, or current rate less than 10% per annum, contrasted with starch-based high fiber diet keeping zero patients in remission; clinical trial. https://www.sciencedirect.com/science/article/pii/S0140673685914977 Fasting mimicking diet shows benefit in inflammatory bowel disease, promotes GI regeneration and reduces IBD pathology in clinical trials https://www.sciencedirect.com/science/article/pii/S2211124719301810 Music track: Acoustic Breeze from Bensound.com #keto #fyp #cancer #cholesterol #carnivore #carnivorediet #weightloss #thecarnivorelife #weightsandsteaks #teamcarnivore #meatheals #yestomeat #nutrition #diet #autoimmune #rugby #rugbyunion #rugbyplayer #weightlossjourney #weightlifting #steak #bodybuilding #strength #strengthtraining #weighttraining #zerocarb #ketovore #ribeye #liondiet #ketodiet #carnivoreketo #ketotransformation #carnivore75hard #vegan #sowell #thomassowell #dairy #milk #cheese #nsng #lchf #lcif
Welcome to the very first episode of our brand new podcast, Med Reg News. And to be more specific, Episode 1 of Gastro News. This is the first of many podcast episodes we'll be producing under the wider family of new podcast resources called Med Reg News. And it's amazing to have you join us for the ride!Within Med Reg News, we're going to start out with a handful of mini-series of episodes focusing on gastroenterology, cardiology and geriatrics, and in due course we hope to cover other medical specialties too. So if you're tuning in to this and you'd like us to put together episodes focused on your own area of medicine, please give us a shout! We'll do whatever we can to help streamline your learning as you take the next step on your journey through the unique and exciting – but sometimes daunting – world of medicine.In Episode 1, we're discussing viral hepatitis with Dr Matthew Cowan, who is a Consultant Gastroenterologist and Hepatologist at the Surrey and Sussex Healthcare Trust. He is also the Lead Clinician for the Nutrition Service and is Honorary Consultant Hepatologist at St George's Hospital, London where he helps run clinical trials of new treatments for viral hepatitis. We're thrilled to have Dr Cowan join us for this opening episode, and would love to hear any questions or feedback you have after hearing our discussion with him. Please get in touch with us on Twitter @medregnews or via email at medregnews@gmail.com. You're the reason we put all of this together. Really hope you enjoy it!
Hepatitis isn't just a virus. Although a virus is a major cause of liver inflammation, so is Tylenol and 3 drinks a day. Hepatitis is a silent disease that takes years to do permanent and deadly harm but if screened and caught early can be treated and avoided. Dr Harrison a world renowned Hepatologist and Gastroenterologist visits with me about screening, prevention, and treatment and gives a simplistic look at a complicated subject. See omnystudio.com/listener for privacy information.
Professor Jacob George is a renowned hepatologist and liver research scientist who studies the causes of and mechanisms for the development of liver disease and liver cancer. Professor George's work has made significant contributions to clinical practice. His team first identified the role of interferon lambda 3 gene polymorphisms for predicting treatment response in chronic hepatitis C, and a second gene polymorphism that interacts with interferon lambda 3. These discoveries are considered major advances in the field and the finest examples of ‘personalized medicine'. Professor George was an author of the groundbreaking study of combination telaprevir, pegylated interferon, and ribavirin therapy for hepatitis C, which changed the landscape of hepatitis C treatments, heralding the era of direct-acting antivirals. His work identifying insulin resistance as the universal underlying pathophysiological abnormality in fatty liver disease underpins the majority of research on this condition and is the cornerstone of current therapy (lifestyle intervention; exercise; insulin-sensitizing agents). He also first described the association between hepatitis C and insulin resistance. Professor George is an advisor to Hepatitis Australia, the Transfusion Related AIDS and Infectious Diseases Service, and at state and national levels, on viral hepatitis. He oversees research for the Asian Pacific Association for the Study of Liver. He is a Fellow of the American Association for the Study of Liver Disease. Professor Jacob George MBBS, FRACP, Ph.D., FAASLD CHAPTERS: 00:00 Intro 00:20 Meet Prof. Jacob George 01:00 Professors In The Hospital 02:30 KPIs For Delivering Clinical Care 03:40 Research & Academic KPIs 05:00 Medical Research Method 06:10 Mice Lab Testing 08:30 How Washing Hands Saved Lives 09:40 Pathophysiology Cycle 11:40 Curing Hepatitis C 12:30 Designing Drugs 14:40 Growing Virus In The Lab 16:00 Hepatitis B Breakthroughs 18:40 Virus Reservoir Forms 20:40 Eliminating Dormant Virus 22:00 Early Phase Human Studies 24:30 Long Term Side Effects 24:50 Thalidomide Scandal 26:00 Clinical Trials 27:00 Post Marketing Research 29:05 Cost vs Benefit 29:45 Independent Experts 31:55 The Covid Vaccines 33:15 Do Masks Work? 35:30 Does Vaccine Works? 37:20 Personal Risk Factors 37:55 The Old Man's Friend 39:05 The Immune Response 41:30 The Immune System 43:05 Natural Immunity 44:30 Immune System Memory 46:15 Average Human Lifespan 47:00 Healthy Aging 48:20 Cancer Development 50:50 The Blue Zone Diet 53:35 Social Constructs On Food Behavior 55:20 The Agricultural Age 57:30 Nutritional Ecology 59:25 Child Rearing Experiment 01:02:15 Knowledge Dissemination 01:04:10 Just A Speck 01:04:35 Outro
The Impact Research Institute (IRI) is Waco, Texas' resource for extending care options for NAFLD (non-alcohol fatty liver disease.) Nadege Gunn is IRI's Medical Director and President. She joined Kevin Stevenson on I Don't Care to discuss her and her team's mission to treat NAFLD and other related diseases and conditions.Dr. Gunn is a Gastroenterologist and Hepatologist whose main passion is the liver. “The liver is an amazing organ,” Dr. Gunn said. “It's the only organ in the body that you could cut in half, and it can grow back in full size in about three months. The work we do in transplantation and replacing the liver is quite amazing, so that's why I chose the field in general.”Dr. Gunn helped open IRI in July of 2021. Necessity created the decision to develop the center. While practicing clinical trials in Austin, Texas, Dr. Gunn saw many patients traveling from the Waco area to receive treatment options for NAFLD. With no scan or clinical trial options available to people in Waco and the surrounding area, Dr. Gunn recognized an opportunity to open a clinic to serve the growing needs.Community outreach is critical to the clinic's role in Waco, TX. When they identify candidates who may have NAFLD, they do a non-invasive scan at the center to determine if the candidate does have the disease. “If they do, then we invite them to maybe participate in a clinical trial because there are no treatments for fatty liver,” Dr. Gunn said.For people wondering if they might have NAFLD, Dr. Gunn said the disease is often asymptomatic in the early stages. “It is when the disease is progressing, when it is starting to injure and harm the liver, that people might start firstly feeling fatigued,” Dr. Gunn said. “They might feel pain in the right upper quadrant of their abdomen and their belly.” Recognizing these warning signs and seeking a diagnosis is critical before full-on cirrhosis of the liver occurs.
PSC Partners Seeking a Cure is pleased to present Living With PSC, a podcast moderated by Niall McKay. Each month, this podcast explores the latest research and knowledge about primary sclerosing cholangitis (PSC), a rare liver disease. From patient stories, to the latest research updates from PSC experts, to collaborations that are necessary to find better treatments and a cure, this podcast has it all! In episode 33 of the Living with PSC Podcast, Host Niall McKay talks with Hepatologist and Senior Research Clinician Theo Heller, MD, and Hepatology Fellow Gracia Viana, MD, National Institute for Health (NIH) Clinical Center, about their primary sclerosing cholangitis (PSC) study. "We want to study the evolution of PSC," says Dr. Heller. "We're proposing a study that has the potential of unraveling some of the most fundamental aspects of the disease." Information about this study will be sent to PSC Partners Registry participants. If you are a PSC patient but have not yet joined the Patient Registry, now would be a good time. www.pscpartnersregistry.org Questions about the Registry? Email: registrycoordinator@pscpartners.org
The Plant Free MD with Dr Anthony Chaffee: A Carnivore Podcast
Dr Pran Yoganathan is a Sydney based Consultant Gastroenterologist and Hepatologist who practices and preaches an animal based diet for himself and his patients. During his career he realized that the standard practices alone weren't giving his patients the help that they needed, so he changed the practice to addressing the elephant in the room: nutrition. This has shown huge benefits to both himself, his patients, and his growing family. He was also my teammate in the recent ACNEM Carnivore vs Vegan debate last November, link below for those who haven't seen it. Join me in this great conversation with a true expert in gut health and nutrition. Dr Pran Yoganathan INSTAGRAM: https://www.instagram.com/dr_pran_yoganathan/ FOLLOW AND CONTACT ME AT: INSTAGRAM: Dr. Anthony Chaffee, MD (@anthonychaffeemd) • Instagram photos and videos TWITTER: @Anthony_Chaffee TIKTOK: @plantfreemd For more of my interviews and discussions, as well as other resources, go to my Linktree at: https://linktr.ee/DrChaffeeMD OR my website at: www.TheCarnivoreLife.com The Carnivore Bar https://carnivorebar.com/ And please like and subscribe to my podcast here and Apple/Google podcasts, as well as my YouTube Channel to get updates on all new content! Resources: ACNEM Healthy Debate (Carnivore v Vegan) https://vimeo.com/644611724/b94e6a7cb0 My expanded Carnivore vs Vegan arguments https://youtu.be/a_zSIpUjfS4 Elemental diet found to be as or more effective as prednisone for acute crohns exacerbations in clinical trial https://www.bmj.com/content/288/6434/1859.abstract Elemental diet better than steroids in children; clinical trial https://adc.bmj.com/content/62/2/123.short Elemental diet better than polymeric diet in treating Crohn's and keeping in remission. Quick absorption, less stress on cut, EG fiber opposite of this. https://www.sciencedirect.com/science/article/pii/014067369090936Y Exclusion diet keeps Crohn's patients in remission for up to 51 months, or current rate less than 10% per annum, contrasted with starch-based high fiber diet keeping zero patients in remission; clinical trial. https://www.sciencedirect.com/science/article/pii/S0140673685914977 Fasting mimicking diet shows benefit in inflammatory bowel disease, promotes GI regeneration and reduces IBD pathology in clinical trials https://www.sciencedirect.com/science/article/pii/S2211124719301810
This season on Behind The M.D., we want to elevate the voices of trailblazers in the Black physician community. We will be doing this in a series we call "Highlighting Excellence". Our inaugural voice in this series is Dr. Naudia Jonassaint, a transplant Hepatologist at The University of Pittsburgh. DISCLAIMER: The views shared in this episode are 100% mine and that of my co-hosts. They do not represent the views of my employer. Our comments should not be used for medical advice.
Whom should you suspect and whom should we screen for this common condition? When should you do the hemochromatosis gene test? How will you make a diagnosis of iron overload? What is the APRI scan, the ferriscan and the fib-4 calculator? How do you use it and what does it mean? Host: Dr David Lim | Total time: 37 mins Guest: Prof John Olynyk, Gastroenterologist & Hepatologist; Fiona Stanley and Fremantle Hospitals; Dean of Clinical Research, School of Medical and Health Sciences, Edith Cowan University, WA Register for our fortnightly FREE WEBCASTS Every second Tuesday | 7:00pm-9:00pm AEST Click here to register for the next one See omnystudio.com/listener for privacy information.
Pancreatic cancer is rare, but it is an aggressive cancer that usually leads to poor outcomes. One of the biggest challenges is diagnosing the cancer early, as it tends to develop silently with few remarkable symptoms. We speak to Dr Rajesh Kumar Paramasivam, Consultant Gastroenterologist & Hepatologist, from Thomson Hospital Kota Damansara, to find out whether pancreatic cancer can be detected early, and how endoscopic ultrasound can be useful in the diagnosis and treatment of the disease.Image credit: Shutterstock
Dr. Eric Shah welcomes Registered Dietitian Neha Shah and Hepatologist, Dr. Vincent Chen, to discuss different diet and nutrition plans that can help patients with Non-Alcoholic Fatty Liver Disease (NAFLD), as well as their experiences with virtual care practices that can make it easier for patients to stay on task with their tertiary care team.
Associate Professor Sally Bell is a gastroenterologist and hepatologist and is the Director of Gastroenterology at Monash Health. Sally completed her Doctorate of Medicine at St Vincent's Hospital, University of Melbourne, Australia in Molecular virology. She then completed a postdoctoral fellowship in IBD at St Mark's Hospital, London. Sally specialises in inflammatory bowel disease with a special interest in pregnancy and IBD, viral hepatitis, chronic liver disease and clinical nutrition. Having been a doctor mentor over the years, Sally was head of the Specialist Training Committee in Gastroenterology (RACP) for 10 years, and has served as a board member of the Gastroenterology Society of Australia and is actively involved with many other professional groups For more information on Sally, please click on this link https://research.monash.edu/en/persons/sally-bell More information about Hanya Oversby can be found on https://hanyaoversby.com.au/
Join Craig as he discusses with Dr. Jonassaint: Do post and pre-transplant statistics differ for the minority population as opposed to the general population? What can the community do to combat liver disease? What steps can UPMC take to ensure transplant equity? Additionally, make sure you listen to our Community Calendar (brought to you by Port Authority Transit Employment) with Debbie Norrell at the end of each of our interviews so you can keep up with what's going on in our Pittsburgh region. Soul Pitt Media's Health & Business Report is sponsored by UPMC, Port Authority Transit, Duquesne Light Co., ThermoFisher Scientific, and Pennsylvania's Children's Health Insurance Program (CHIP).
Dr Philip Smith, Social Media and Associate Editor of FG and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews members of the UK ‘Green Endoscopy' group, Dr James Maurice, Hepatology registrar at St Mary's Hospital in London, Dr William Stableforth, Hepatologist and Gastroenterologist at the Royal Cornwall Hospital, and Dr Bu Hayee Consultant Gastroenterologist, King's College Hospital, London. This podcast focuses on the groups' work to date and the paper 'Green endoscopy: using quality improvement to develop sustainable practice' which was published online in Frontline Gastroenterology in 2021. Related article: https://fg.bmj.com/content/early/2021/06/07/flgastro-2021-101874
Dr Cyriac Abby Philips is a firebrand twitter sceptic who regularly shares science-based information and research regarding alternative medicine – Ayurveda in particular. He's a Hepatologist and has been studying the side effects of Ayurvedic preparations on the liver. His research and clinical cases have discovered how many Ayurvedic preparations may be harming you more than healing you!He joins us to answer some critical questions about how Ayurveda can be harmful. There are so many real side effects these real herbs can have, but they are being touted as completely side-effect free. People's lives have been put in danger, and some have been lost due to this form of quackery. Even I found many of his findings shocking to say the least! If you have questions for Dr Abby Philips, find him on Twitter @drabbyphilips. Intro and outro music: Heat by DistillFor the full transcript along with links to citations and further reading, please visit www.berationable.com. Questions, suggestions or just want to get in touch? Find me on Instagram and Twitter @berationable. Join the conversation on the Rationable Conversations Facebook group. Contact me at abhijit@berationable.com. For more content like this, visit www.berationable.com. Support and get involved with Rationable on Patreon at patreon.com/rationable.
Learn from the experts about the latest in Immune Mediated Liver Toxicities. Join our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest expert and Transplant Hepatologist Dr. Lindsay King. Dr. King is a Hepatologist, Assistant Professor of Medicine at Duke University School of Medicine.
In this episode, hepatologist Dr. Parvez Mantry joins our host Dr. Christopher Beck to discuss portal hypertension and ascites, two complications that arise from liver diseases and have a large effect on patients’ quality of life. Dr. Mantry starts the episode by sharing statistics on Chronic Liver Disease (CLD) and specifically highlights the burden of CLD on the U.S. population. He discusses various causes of CLD, including Hepatitis C, Alcohol Liver Disease, and Non-Alcoholic Steatohepatitis. Next, Dr. Mantry takes us through his diagnostic workup, including his physical examination, cross-sectional imaging, percutaneous and transjugular liver biopsies, and serological workup. He checks for complications such as portal hypertension, ascites, pedal edema, and hepatic encephalopathy. We also discuss the diagnosis of Hepatocellular Carcinoma (HCC). Then, we transition to strategies for managing ascites and portal hypertension through diuretics, paracentesis, Transjugular Intrahepatic Portosystemic Shunts (TIPS), liver transplantation, and a few experimental treatments that he is currently researching. Overall, Dr. Mantry advocates for close monitoring of symptoms and making treatment modifications as needed. Finally, when focusing on the patient experience, Dr. Mantry offers troubleshooting tips, especially for patients who struggle with leakage from the paracentesis site. To close, he gives insights on how physicians can best support chronically-ill patients who are awaiting transplantation. RESOURCES MENTIONED: Methodist Transplant Specialists- https://www.theliverinstitutetx.com/ Information about Dr. Mantry’s transplant center and its satellite locations in the Dallas-Ft. Worth Community. American Association for the Study of Liver Diseases (AASLD) Practice Guidelines- https://www.aasld.org/publications/practice-guidelines Management of HCC- https://www.journal-of-hepatology.eu/article/S0168-8278(12)60009-9/pdf The Management of Ascites in Cirrhosis- https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1053/jhep.2003.50315 Guidelines set by the International Ascites Club BackTable Endovascular Podcast, Ep. 123- TIPS University Freshman Year: Referrals and Pre-Op Workup- https://www.backtable.com/podcast/123/tips-university-freshman-year-referrals-pre-op-workup
May is just around the corner which means Crohns and Colitis Awareness Month is too. This month aims to bring attention to Inflammatory Bowel Disease which close to 85,000 Australians are affected by. Crohn’s disease and ulcerative colitis are the two most common types of inflammatory bowel disease. San Gastroenterologist and Hepatologist, Dr Aviv Pudipeddi who has a particular interest in the diagnosis and management of inflammatory bowel disease, including ulcerative colitis and Crohn’s disease joins John Stanley. See omnystudio.com/listener for privacy information.
I bet you know someone directly or indirectly who is waiting for a kidney transplant, has received one or died waiting. Organ Donation is personal. I've lost people who were on the waiting list but didn't get a match in time. April is National Donate Life Month which helps to encourage Americans to register as organ, eye and tissue donors and to honor those that have saved lives through the gift of donation. We bring you an excerpt of a FB Live panel discussion with:Howard M. Nathan, President & CEO, Gift of Life Donor Program Cynthia London, Donor Mom & Gift of Life Donor Program Board Member Ramona Howard, Multi-Organ Transplant Recipient Dr. Kimberly A. Forde, MD, PhD, MHS, Associate Professor of Medicine, Lewis Katz School of Medicine and Hepatologist, Temple University Hospital. We hope by the end you'll be inspired to sign up as an organ donor. https://www.donors1.org/But first – jobs are coming back – are you ready? I speak with Philadelphia OIC President and CEO Judge Renée Cardwell Hughes about the job outlook post pandemic and the job training and academic programs preparing individuals for the evolving workforce.https://www.philaoic.org/
I bet you know someone directly or indirectly who is waiting for a kidney transplant, has received one or died waiting. Organ Donation is personal. I've lost people who were on the waiting list but didn't get a match in time. April is National Donate Life Month which helps to encourage Americans to register as organ, eye and tissue donors and to honor those that have saved lives through the gift of donation. We bring you an excerpt of a FB Live panel discussion with:Howard M. Nathan, President & CEO, Gift of Life Donor Program Cynthia London, Donor Mom & Gift of Life Donor Program Board Member Ramona Howard, Multi-Organ Transplant Recipient Dr. Kimberly A. Forde, MD, PhD, MHS, Associate Professor of Medicine, Lewis Katz School of Medicine and Hepatologist, Temple University Hospital. We hope by the end you'll be inspired to sign up as an organ donor. https://www.donors1.org/First - Pennsylvania has ended the moratorium on utility shutoffs and the pandemic has put a strain on many household's finances. There is help. I speak to Funmi Williamson, Senior Vice President at PECO's and Chief Customer who shares information on the many programs to provide bill relief. www.peco/billrelief.
I bet you know someone directly or indirectly who is waiting for a kidney transplant, has received one or died waiting. Organ Donation is personal. I've lost people who were on the waiting list but didn't get a match in time. April is National Donate Life Month which helps to encourage Americans to register as organ, eye and tissue donors and to honor those that have saved lives through the gift of donation. We bring you the uncut edition of a FB Live panel discussion with:Howard M. Nathan, President & CEO, Gift of Life Donor Program Cynthia London, Donor Mom & Gift of Life Donor Program Board Member Ramona Howard, Multi-Organ Transplant Recipient Dr. Kimberly A. Forde, MD, PhD, MHS, Associate Professor of Medicine, Lewis Katz School of Medicine and Hepatologist, Temple University Hospital. We hope by the end you'll be inspired to sign up as an organ donor. https://www.donors1.org/
Dr. Daniel Ganger, Hepatologist at Northwestern Medicine, and Mary discuss the difference between congestive hepatopathy and Fontan Associated Liver Disease (FALD) as well as when a Heart - Liver Transplant may need to be considered.
In this episode of Bowel Sounds, hosts Drs. Peter Lu and Jennifer Lee talk to Dr. Evelyn Hsu about liver transplantation in children and how to become a pediatric transplant hepatologist. We talk about what inspired her to become a transplant hepatologist and introduce the topic of pediatric liver transplantation, including its indications, contraindications, and the components of transplant evaluation. We discuss the improvements in transplant outcomes over time and the new standards for a successful outcome. Finally, we talk about transplant hepatology fellowship training and what the Society of Pediatric Liver Transplantation (SPLIT) is doing to help educate GI trainees with an interest in liver transplantation.As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.References:Dominique Ansel's MasterClass on French Pastry FundamentalsHyperbole and a Half by Allie BroshThe Great Pottery Throw Down on HBOThe American Barbecue Showdown on NetflixSociety of Pediatric Liver Transplantation (SPLIT) websiteProduced by: Peter LuSpecial requests:Thank you to everyone for listening to our podcast. If you enjoyed this content and thought it was useful, we ask you to consider doing any or all of the following three things:Tell one person that you think would like this type of content about the podcast. We want to reach more GI doctors and trainees as well as general pediatricians, pediatric residents and medical students.Leave a review on Apple Podcasts -- this helps more people discover our podcast.You can also support the show by making a donation to the NASPGHAN Foundation via the link below.Support the show (https://www.naspghan.org/content/87/en/foundation/donate)
Dr. Mona Hassan is a transplant heptatologist and assistant professor at the University of Toledo. She completed my internal medicine residency in Detroit Michigan and then went on to complete fellowships in gastroenterology and transplant heptatologist at Henry Ford Hospital in Detroit. Dr. Hassan is also an associate program director for the gastroenterology fellowship program at the University of Toledo. Her Book: Steps to Happiness, which is a personal guide to feeling happier through simple everyday steps. Can be found on amazon. https://www.amazon.com/Steps-Happiness-Mona-Hassan-Alaali/dp/1716936055/ref=sr_1_2?crid=X6RILYKMBWVL&dchild=1&keywords=steps+to+happiness+mona+hassan&qid=1612840197&sprefix=mona+hassan%2Caps%2C190&sr=8-2
The Howard Alumni Movemakers Podcast hosted by Joshua Mercer
THIS IS NOT AN OFFICIAL PUBLICATION OF HOWARD UNIVERSITY*** ________ Follow On Instagram: https://www.instagram.com/howardalumni/ Facebook Group: https://facebook.com/howardalumni Follow on Twitter: https://twitter.com/howardalumni Subscribe to Newsletter: https://www.humovemakers.com/ Howard Homecoming: https://www.homecomingathoward.com/ ________ Welcome to the HU Movemakers Podcast (www.humovemakers.com), where we highlight folks in Howard University Culture that are blazing the trail and making moves! If you would like to apply or nominate someone to be on the podcast, please email bio/headshot to humovemakers@gmail.com. _________ Dr. Gia Tyson is a transplant hepatologist for Ochsner Health in Louisiana. As the only liver specialist in the Baton Rouge region she has multiple jobs. She started The Liver Center Ochsner Baton Rouge to provide high level liver care to the region. Dr. Tyson is head of The Liver Center, which has grown significantly over the past 6 years and receives referrals from around the state. She is also a Clinical Assistant Professor of Medicine at Louisiana State University where she staffs the liver disease clinic with LSU Baton Rouge residents and provides care to the underserved. At LSU she gives didactic lectures to the residents and medical students. She also started a special program at LSU where primary care providers can give specialized care by treating hepatitis C virus (HCV) positive patients. Dr. Tyson utilizes her Master of Public Health degree and clinical expertise as the Clinical Network Specialist for the Louisiana Department of Health's initiative to eliminate hepatitis C (HepCured LA). Louisiana is the first start to have this type of public initiative. In this role she has helps create the training documents and provides the training to primary providers around the state of Louisiana to treat HCV. In less than one year, the HepCured LA initiative has created over 300 new hepatitis C treaters and treated more the 4,200 persons with HCV. More patients on Medicaid have been treated than the previous 5 years combined. She has published multiple peer reviewed articles on hepatitis C, hepatitis B and hepatocellular carcinoma. Dr. Tyson is also an entrepreneur. She is the founder and CEO of Med School Admit (MSA). MSA has programs focused on helping premedical students become competitive medical school applicants. She is proud of all the work she is doing to create healthier Louisianans and is particularly motivated to make an impact on students around the country who want to see their dreams of becoming a doctor realized. Dr. Tyson is a native of New Orleans, Louisiana who attend college at Howard University, Harvard Medical School, Johns Hopkins for residency, Baylor for GI fellowship and Tulane for transplant hepatology. She is a wife and mother of three children who in her spare time enjoys movies and endurance sports. While at Howard University Dr. Tyson was very involved. She was a student athlete, playing tennis for 3 years and serving as team captain. She served as junior class president in the College of Arts and Sciences. She was a member of Phi Sigma Pi honor fraternity and Alpha Kappa Alpha Sorority, Inc. During her senior year she was the president of Alpha Kappa Alpha. She took full advantage of her Howard years, researching at the National Institutes of Health and travelling to Africa during her summers. Given her well rounded activities while maintaining a 4.0 gpa Dr. Tyson applied for the Rhode's Scholarship and was a finalist. Above all Dr. Tyson is grateful for the amazing and lifelong friendships she formed at Howard that are ongoing. __________ THIS IS NOT AN OFFICIAL PUBLICATION OF HOWARD UNIVERSITY*** --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/humovemakers/message Support this podcast: https://anchor.fm/humovemakers/support
Thanks for tuning in to the Armor Men's Health Hour Podcast today, where we bring you the latest and greatest in urology care and the best urology humor out there.In this segment, Dr. Mistry and Donna Lee are joined by special guest, hepatologist and gastroenterologist Dr. Nadege Gunn of Pinnacle Clinical Research. Today, Dr. Mistry and Dr. Gunn discuss the causes, progression, and treatment of liver disease. She explains what is "fatty" in a fatty liver, and why anyone with fatty liver will invariably need to lose at least some weight. Finally, she describes the different phases of medical research with which she is involved and how listeners can obtain their free fibroscan as part of the research process. You can contact Dr. Gunn at Dr. Gunn: (512) 384-1560. Dr. Mistry is a board-certified urologist and has been treating patients in the Austin and Greater Williamson County area since he started his private practice in 2007.We enjoy hearing from you! Email us at armormenshealth@gmail.com and we'll answer your question in an upcoming episode!Phone: (512) 238-0762Email: Armormenshealth@gmail.comWebsite: Armormenshealth.comOur Locations:Round Rock Office970 Hester's Crossing Road Suite 101 Round Rock, TX 78681South Austin Office6501 South Congress Suite 1-103 Austin, TX 78745Lakeline Office12505 Hymeadow Drive Suite 2C Austin, TX 78750Dripping Springs Office170 Benney Lane Suite 202 Dripping Springs, TX 78620
Thanks for tuning in to the Armor Men's Health Hour Podcast today, where we bring you the latest and greatest in urology care and the best urology humor out there.In this segment, Dr. Mistry and Donna Lee are joined by special guest, hepatologist and gastroenterologist Dr. Nadege Gunn of Pinnacle Clinical Research. Today, Dr. Mistry and Dr. Gunn discuss the causes, progression, and treatment of liver disease. She explains what is "fatty" in a fatty liver, and why anyone with fatty liver will invariably need to lose at least some weight. Finally, she describes the different phases of medical research with which she is involved and how listeners can obtain their free fibroscan as part of the research process. You can contact Dr. Gunn at Dr. Gunn: (512) 384-1560. Dr. Mistry is a board-certified urologist and has been treating patients in the Austin and Greater Williamson County area since he started his private practice in 2007.We enjoy hearing from you! Email us at armormenshealth@gmail.com and we'll answer your question in an upcoming episode!Phone: (512) 238-0762Email: Armormenshealth@gmail.comWebsite: Armormenshealth.comOur Locations:Round Rock Office970 Hester's Crossing Road Suite 101 Round Rock, TX 78681South Austin Office6501 South Congress Suite 1-103 Austin, TX 78745Lakeline Office12505 Hymeadow Drive Suite 2C Austin, TX 78750Dripping Springs Office170 Benney Lane Suite 202 Dripping Springs, TX 78620
Deepak Suri is a Hepatologist and Gastroenterologist at UCLH and the Whittington. He joins us to discuss all things liver, including Hepatitis, VOD, GVHD and Haemochromatosis.
Yesterday, the Road Transport (Amendment) Bill 2020 was tabled in Parliament, to address reckless and dangerous driving along with driving under the influence of drugs as well as alcohol. Apart from drink driving-related fatalities, alcohol consumption also leads to other harmful and potentially life-threatening consequences, which don’t often make the headlines. Dr Saravana Kumar Karunanathy, Consultant Gastroenterologist and Hepatologist from Parkcity Medical Centre, joins us to discuss alcohol-related liver disease. Image Source: Pexels
Ponni Perumalswami treats patients who have advanced liver diseases. She also is working to reach communities at risk for viral hepatitis B and C to connect them to testing, education, and healthcare. She explains The differences, such as transmission means, between hepatitis B and C; The reason why some foreign-born communities are at risk and how her group is trying to make their way into the center of these groups; and Why these diseases of the liver, while usually asymptomatic for years, can cause damage leading to treatments like liver transplantation. Ponni Perumalswami is an associate professor of medicine in the Division of Liver Diseases at Mt. Sinai School of Medicine. She tells listeners that there's an at-risk population for hepatitis B and C that she and her colleagues are targeting. In the U.S., while the diseases are less common in the general population, at-risk groups who immigrate from areas with higher rates, specifically Asian and African-born communities, are hard to reach. Because they may not have insurance and are not English speakers, they aren't in touch with primary care doctors who might normally screen for these diseases and they can be asymptomatic for years. Her outreach efforts include testing within the communities and awareness-raising efforts. Dr. Perumalswami explains how these diseases work. She explains that hepatitis B is a DNA virus that largely infects foreign-born populations because the U.S. has had the means to vaccinate and test for this disease. It spreads by a vertical transmission from mother to child. Hepatitis C is transmitted through blood exposures, so through intravenous drug use, blood transfusions, and organ donations done before 1992 when testing became available. Even though each can exist in the body silently for years, they can still do tremendous damage in the liver, and increase one's risk for cirrhosis, cancer, and other disease of the liver that may need liver transplantation. For more, see the Mt. Sinai Liver Diseases Division website https://www.mountsinai.org/care/liver-diseases/research Available on Apple Podcasts: apple.co/2Os0myK
Dr. Kalra is a community transplant hepatologist that enjoys a busy, but exciting lifestyle. We talk about the path to transplant hepatology, myths, and more!
All this week is Haemochromatosis Awareness Week. Sinead Denny who was diagnosed with Haemochromatosis in 2012 and Professor Suzanne Norris a Hepatologist and Gastroenterologist from St James’ Hospital In Dublin join Ray on the line.
Dr Marno Ryan is a Gastroenterologist and Hepatologist with a special interest in fatty liver disease which is fast becoming a serious health issue not only in Australia but throughout the world. She says that despite 30% of the population in Australia having the disease, not everyone will go on to develop more serious liver issues such as non-alcoholic steato-hepatitis (NASH). But for those who do develop NASH, losing between 5-10% of body weight can make a really positive difference she says. Listen to find out the best diet and drinks for liver health.
Colorectal cancer still ranks high among cancers affecting Malaysians, and is still being diagnosed at late stages. How does this affect patients’ treatment and outcome? And how can we improve early detection of colorectal cancer, and what are the advances in treatment that show promise in treating the cancer? We speak to Dato’ Dr Tan Huck Joo, Consultant Gastroenterologist & Hepatologist, Cengild G.I. Medical Centre, to find out more.
Colorectal cancer still ranks high among cancers affecting Malaysians, and is still being diagnosed at late stages. How does this affect patients’ treatment and outcome? And how can we improve early detection of colorectal cancer, and what are the advances in treatment that show promise in treating the cancer? We speak to Dato’ Dr Tan Huck Joo, Consultant Gastroenterologist & Hepatologist, Cengild G.I. Medical Centre, to find out more.
Dr. Hina was born in Karachi, Pakistan but grew up in the United States from the age of 11. Her family settled in Darien, Connecticut where she attended middle and high school. After high school, she attended a combined 8 year BS/MD program at Union College / Albany Medical College. She received a Masters in Health Management at Union College as well. After completing medical school, Dr. Hina started Internal Medicine residency at Albert Einstein College of Medicine/ Montefiore Medical Center. She stayed on to do a one year fellowship to specialize in liver disease. She then did a three year fellowship in Gastroenterology at Northwell. After completing her education and training, she started her current position as Gastroenterologist and Hepatologist at ProHealth in Lake Success, NY. She lives in Long Island with her husband and children. In her free time, she enjoy reading and traveling with her family.
Dr. Scott Magill of VIDOL joins Tom Zawistowski, President, of We the People Convention.”about case of the students from Covington, Ky that were berated and sent death threats from their trip to Washington, D.C. Dr. Robert G. Gish, Hepatologist, discusses the risk factors importance of seeking care of Chronic Hepatitis C (HCV) – A Curable Disease. Chris McGinnis of TravelSkills shares his insider advice for Snagging the Best Travel Deals & Destinations for 2019.This show is broadcast live on Thursday's 2PM ET on W4CY Radio – (www.w4cy.com) part of Talk 4 Radio (http://www.talk4radio.com/) on the Talk 4 Media Network (http://www.talk4media.com/
Do you know how you get Hepatitis? Do you like to travel? Have you been considering getting a tattoo overseas? Do you know if you have Hepatitis? Do you work with patients in a healthcare environment? Are you the type of person that if you witnessed an accident you would step in to try to help someone in need? I know I would answer ''yes'' to some of these questions mentioned above. If you also found yourself also saying ''yes'' to a few of these questions too then take a minute out of your day or night and educate yourself and listen to this podcast on hepatitis. In 15 mins learn from a leading Hepatolgist about Hepatitis A-B-C. According to Hepatitis Victoria, ''500 000 Australians are living with Hep C and B''. Shockingly, 65% of us don't know that we have it. Diagnosing and managing a disease is about educating ourselves about it. Did you know there was for instance, different types of Hepatitis - Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D and Hepatitis E. You can listen on the go to MeditalkPodcast on iTunes, SoundCloud and your trusty Podcasts App. Meditalk provides medical information in a way that you can understand and I interview well respected medical specialists and health professionals on health & medical topics we should know more about so, we can make more informed decisions about our health and the health of our family. This MediTalk podcast is on 'Hepatitis' and I speak with A/Prof Lindsay Mollison a Gastroenterologist and Hepatologist as well as, having qualifications in Infectious Diseases. Dr Mollison consults at Riverview Endoscopy. Find out more about Dr Mollison and his A-B-C Liver Clinic: www.riverviewendo.com.au For further information and support about Hepatitis: WA listeners can contact Hepatitis WA www.hepatitiswa.com.au Australia wide Hepatitis Association contact: www.hepatitisaustralia.com For American listeners - Hepatitis Support liverfoundation.org In major cities around the world there are often excellent Hepatitis-Liver Foundations to provide education and support - search online to find an association near you. Listening and learning more about Hepatitis via this podcast is a great start and always reach out and speak with your doctor if you are concerned and need medical help.
Marion Peters, MD, UCSF. Hepatologist. Series: "UCSF Transplant Update" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 33249]
Marion Peters, MD, UCSF. Hepatologist. Series: "UCSF Transplant Update" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 33249]
Danielle Brandman, MD, UCSF. Hepatologist. Series: "UCSF Transplant Update" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 33248]
Danielle Brandman, MD, UCSF. Hepatologist. Series: "UCSF Transplant Update" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 33248]
In this episode we discuss non-alcoholic fatty liver disease or NAFLD with Dr Jon Mitchell, Hepatologist and Head of Gastroenterology at the Sunshine Coast University Hospital. We discuss: - What is NAFLD? - What is the prevalence? - How is it caused? - What is the spectrum and complications of NAFLD? - What investigations are useful? - What is the management? - Is coffee good for the liver? - What is the origin of the Fibroscan?
Today we are joined by Dr Hans Seltenreich Gastroenterologist and Hepatologist and founder of the Coastal Digestive Health clinic on the Sunshine Coast, QLD. We have a yarn about the gut microbiome/microbiota and the role of faecal transplants. In particular: 1. What is the microbiome? 2. What is it impacted by? 3. What are its roles in the human body? 4. What is its role in disease? 5. What is the role of faecal transplants? As always - enjoy.
A study conducted by the University of Cape Town has found that there is a prevalence of hepatitis C in high risk population namely sex workers, men who have sex with men and people who use drugs. Hepatitis B and hepatitis C are infectious diseases that affect the liver . Tsepiso Makwetla spoke to Associate Professor and Hepatologist at Groote Schuur Hospital and University of Cape Town, Mark Sonderup...
Audible Article by Dina L. Halegoua-De Marzio M.D., and Steven K. Herrine M.D..
Audible Article by Dina L. Halegoua-De Marzio M.D., and Steven K. Herrine M.D..
A hepatologist and academic, a wife and a mother of two, Dr Ellie Barnes delighted researchers at the Wellcome Trust Centre for Human Genetics’ Women in Science talk, held on Wednesday the 20th of November 2013 Her presentation entitled: Women in Science – the joys and the juggles, highlighted the ups and downs of balancing a career in science, particularly as a working mother. Currently balancing three major projects: leading a £5 million collaboration called Stop HCV, trialling a powerful new Hepatitis C vaccine, and studying B cell immunology and IgG4 systemic disease, Ellie is now at a senior level in her career. But she admited that getting to this point hasn’t exactly been smooth sailing. Having her first child while studying her PhD and second just before receiving her intermediate MRC award, Ellie said it’s often hard to manage the demands of work and home, but being able to do what you love day in and day out makes it worth the struggle.
A hepatologist and academic, a wife and a mother of two, Dr Ellie Barnes delighted researchers at the Wellcome Trust Centre for Human Genetics’ Women in Science talk, held on Wednesday the 20th of November 2013 Her presentation entitled: Women in Science – the joys and the juggles, highlighted the ups and downs of balancing a career in science, particularly as a working mother. Currently balancing three major projects: leading a £5 million collaboration called Stop HCV, trialling a powerful new Hepatitis C vaccine, and studying B cell immunology and IgG4 systemic disease, Ellie is now at a senior level in her career. But she admited that getting to this point hasn’t exactly been smooth sailing. Having her first child while studying her PhD and second just before receiving her intermediate MRC award, Ellie said it’s often hard to manage the demands of work and home, but being able to do what you love day in and day out makes it worth the struggle.
We Live! We Walk! We gear our lives to get to and maintain a solidly average weight. If we don't we put ourselves at risk of heart disease, diabetes, and looking downright unfit. But we can be fit! If we eat less and move more. The more you move, the less you eat, the more you lose.Music is 13 minutes of Exercise Time: Resurrection Cemetery by Chachi On AcidThe New Year by Love=ActionNew Year by Emissary All from Mevio.com commonly known as Music Alley Dot Calm Don't take any medical advice from a music blogger/podcast. It's dangerous. Listen to your Hepatologist (a Liver specialist)
A hepatologist and academic, a wife and a mother of two, Dr Ellie Barnes delighted researchers at the Wellcome Trust Centre for Human Genetics’ Women in Science talk, held on Wednesday the 20th of November 2013. Her presentation entitled: Women in Science – the joys and the juggles, highlighted the ups and downs of balancing a career in science, particularly as a working mother. Currently balancing three major projects: leading a £5 million collaboration called Stop HCV, trialling a powerful new Hepatitis C vaccine, and studying B cell immunology and IgG4 systemic disease, Ellie is now at a senior level in her career. But she admited that getting to this point hasn’t exactly been smooth sailing. Having her first child while studying her PhD and second just before receiving her intermediate MRC award, Ellie said it’s often hard to manage the demands of work and home, but being able to do what you love day in and day out makes it worth the struggle.
© 2020-2025 Ivy Podcast Discovery LLC
